SNO 2018: Novel Vaccine Targeting IDH1R132H Is Safe and Immunogenic in Newly Diagnosed Malignant Astrocytoma
This was the first in-human, multicenter, phase I clinical trial of the vaccine.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.